Database and news
Peptides
Research peptides, clinic marketing, access and quality risk coverage
Peptide regulatory status tracker
Where each peptide stands with FDA: its 503A bulks-list status, any FDA-approved product, advisory committee votes and anti-doping status, with the source for every change.
- FDA-approved Hormones & metabolism
Albiglutide
Albiglutide is a once-weekly GLP-1 drug approved in 2014 as Tanzeum for type 2 diabetes. Learn how it works, what trials found, and why it was withdrawn.
- Not FDA-approved Hormones & metabolism
Compounded Tesamorelin
Tesamorelin is FDA-approved only for HIV-associated lipodystrophy. See what is known about off-label body composition and anti-aging use in people without HIV.
- FDA-approved Hormones & metabolism
Corticotropin
ACTH
Corticotropin (ACTH) stimulates the adrenal glands and acts on immune cells. Learn what it is, how it works, and its FDA-approved status since 1952.
- FDA-approved Hormones & metabolism
Cosyntropin
Cosyntropin is a synthetic ACTH fragment used to test adrenal function. Learn how the cortisol response is read and what FDA-approved means here.
- FDA-approved Hormones & metabolism
Dulaglutide
Dulaglutide is an FDA-approved once-weekly GLP-1 receptor agonist for type 2 diabetes. Learn how it works, what trials showed, and its cardiovascular role.
- In clinical trials Hormones & metabolism
Efpeglenatide
Efpeglenatide is an investigational once-weekly GLP-1 receptor agonist. Learn how it works, what the AMPLITUDE-O trial found, and why it is not yet approved.
- In clinical trials Hormones & metabolism
Elamipretide
Elamipretide is a mitochondria-targeting peptide with FDA accelerated approval for Barth syndrome. Learn how it works and what that approval does not show.
- FDA-approved Hormones & metabolism
Exenatide
Exenatide is a GLP-1 agonist FDA-approved in 2005 for type 2 diabetes. Learn how it works, its history, and why the U.S. brands were discontinued.
- Not FDA-approved Hormones & metabolism
Humanin
Humanin is a mitochondria-encoded peptide studied for aging and brain protection. Learn what research shows, why evidence is limited, and its FDA status.
- FDA-approved Hormones & metabolism
Insulin analogs
Insulin analogs are engineered insulins that act faster or last longer. Learn how they work, their uses, their FDA status, and side effects.
- FDA-approved Hormones & metabolism
Lixisenatide
Lixisenatide is a once-daily GLP-1 receptor agonist FDA-approved in 2016 for type 2 diabetes. See how it works, its status, and side effects.
- FDA-approved Hormones & metabolism
Mecasermin
Mecasermin is recombinant IGF-1, FDA-approved since 2005 for children with severe primary IGF-1 deficiency. Learn how it works and who it is for.
- Not FDA-approved Hormones & metabolism
MOTS-c
MOTS-c is a mitochondrial peptide studied as an exercise mimetic. See what preclinical research shows, why human evidence is lacking, and its FDA status.
- FDA-approved Hormones & metabolism
Pasireotide
Signifor
Pasireotide (Signifor) is an FDA-approved somatostatin analog for Cushing's disease and acromegaly. Learn how it works and why it raises blood sugar.
- FDA-approved Hormones & metabolism
Pegvisomant
Pegvisomant (Somavert) is an FDA-approved growth hormone receptor blocker for acromegaly. Learn how it lowers IGF-1, how it is given, and the research.
- FDA-approved Hormones & metabolism
Pramlintide
Pramlintide is an FDA-approved amylin analog used with mealtime insulin. Learn how it lowers after-meal glucose and how it differs from GLP-1 drugs.
- FDA-approved Hormones & metabolism
Secretin
Secretin is the first hormone ever discovered and an FDA-approved diagnostic agent. Learn how it tests pancreatic function and what the evidence shows.
- FDA-approved Hormones & metabolism
Somapacitan
Sogroya
Somapacitan is a long-acting growth hormone, FDA-approved since 2020, given once weekly. Learn how it works, who it is for, and how it differs from daily doses.
- FDA-approved Hormones & metabolism
Somatropin (rhGH)
rhGH
Somatropin is lab-made human growth hormone, FDA-approved since the late 1980s. Learn its approved uses, how it works, and the safety considerations involved.
| Peptide | Status | 503A bulks list | FDA-approved product | WADA |
|---|---|---|---|---|
| Albiglutide | FDA-approved | Not nominated Since Sept. 28, 2026, as of Oct. 27, 2026 | Yes — see profile | Not listed |
| Compounded Tesamorelin | Not FDA-approved Research use only Compounded (503A) | Not nominated Since Sept. 28, 2026, as of Oct. 27, 2026 | None | Prohibited |
| Corticotropin ACTH | FDA-approved | Not nominated Since Sept. 28, 2026, as of Oct. 27, 2026 | Yes — see profile | Not listed |
| Cosyntropin | FDA-approved | Not nominated Since Sept. 28, 2026, as of Oct. 27, 2026 | Yes — see profile | Not listed |
| Dulaglutide | FDA-approved | Not nominated Since Sept. 28, 2026, as of Oct. 27, 2026 | Yes — see profile | Not listed |
| Efpeglenatide | Not FDA-approved Investigational | Not nominated Since Sept. 28, 2026, as of Oct. 27, 2026 | None | Not listed |
| Elamipretide | FDA-approved | Not nominated Since Sept. 28, 2026, as of Oct. 27, 2026 | Yes — see profile | Not listed |
| Exenatide | FDA-approved | Not nominated Since Sept. 28, 2026, as of Oct. 27, 2026 | Yes — see profile | Not listed |
| Humanin | Not FDA-approved Research use only | Not nominated Since Sept. 28, 2026, as of Oct. 27, 2026 | None | Not listed |
| Insulin analogs | FDA-approved | Not nominated Since Sept. 28, 2026, as of Oct. 27, 2026 | Yes — see profile | Not listed |
| Lixisenatide | FDA-approved | Not nominated Since Sept. 28, 2026, as of Oct. 27, 2026 | Yes — see profile | Not listed |
| Mecasermin | FDA-approved | Not nominated Since Sept. 28, 2026, as of Oct. 27, 2026 | Yes — see profile | Not listed |
| MOTS-c | Not FDA-approved Research use only | Advisory committee voted to include Since July 22, 2026, as of Oct. 27, 2026 | None | Prohibited |
| Pasireotide Signifor | FDA-approved | Not nominated Since Sept. 28, 2026, as of Oct. 27, 2026 | Yes — see profile | Not listed |
| Pegvisomant | FDA-approved | Not nominated Since Sept. 28, 2026, as of Oct. 27, 2026 | Yes — see profile | Not listed |
| Pramlintide | FDA-approved | Not nominated Since Sept. 28, 2026, as of Oct. 27, 2026 | Yes — see profile | Not listed |
| Secretin | FDA-approved | Not nominated Since Sept. 28, 2026, as of Oct. 27, 2026 | Yes — see profile | Not listed |
| Somapacitan Sogroya | FDA-approved | Not nominated Since Sept. 28, 2026, as of Oct. 27, 2026 | Yes — see profile | Not listed |
| Somatropin (rhGH) rhGH | FDA-approved | Not nominated Since Sept. 28, 2026, as of Oct. 27, 2026 | Yes — see profile | Not listed |
Source: FDA 503A bulks-list categories, PCAC meeting materials and the WADA Prohibited List
Status labels Not FDA-approved Research use only FDA-approved Investigational Compounded (503A)
What each label means
- Not FDA-approved
- No FDA approval for any use in humans.
- Research use only
- Sold as a "research chemical" not for human use. Not FDA-approved; FDA considers such products unapproved new drugs when marketed for human use.
- FDA-approved
- FDA has approved this drug or biologic as safe and effective for its labeled use.
- Investigational
- Being studied in clinical trials; not approved by FDA for any use.
- Compounded (503A)
- Prepared by a state-licensed 503A pharmacy for an individual patient prescription. Compounded drugs are not FDA-approved.
About peptide status
Most peptides discussed here are not FDA-approved for any use, and products labeled “research use only” are not for human use. Removal from Category 2 does not authorize compounding. PCAC votes are non-binding recommendations; FDA and HHS make the final decisions.
This is not medical or legal advice, and we do not publish dosing, sourcing or reconstitution information. Talk with a licensed clinician before using any peptide.
If you think you are having a medical emergency, call 911.
Methodology
Data sources
What we include
- Peptides that are marketed to consumers through telehealth, compounding pharmacies or “research use only” sellers, or that FDA or its advisory committee has reviewed for the 503A bulks list.
- The 503A status is the one on FDA’s published lists on the “status as of” date; advisory committee votes are recorded as non-binding recommendations.
How we verify
- Every status change is dated and linked to the FDA page or meeting materials it comes from.
- Profiles are reviewed by a clinician or pharmacist on our medical review panel.
Known gaps
- 503B (outsourcing facility) status is recorded only when FDA has stated it.
- Advisory committee outcomes are sometimes reported before FDA posts minutes; those records say so.
- Human trial counts cover registered trials we reviewed, not every published study.
Update frequency: Checked at least weekly and whenever FDA updates its 503A lists or holds a PCAC meeting.
CSV columns (19)
-
profile_url - Peptide profile on this site.
-
name - Peptide name.
-
synonyms - Other names, separated by semicolons.
-
status_503a - 503A bulks-list status code.
-
status_503a_label - 503A bulks-list status in plain English.
-
status_503b - 503B (outsourcing facility) status, when known.
-
fda_approved - true when an FDA-approved drug product contains the peptide.
-
approved_product - The FDA-approved product, when there is one.
-
wada - World Anti-Doping Agency status (Prohibited, Not listed, Not assessed).
-
dea_schedule - DEA controlled-substance schedule, when assessed.
-
status_labels - Status Label codes shown on the page, separated by semicolons.
-
last_status_change - Date of the current 503A status (YYYY-MM-DD): the advisory committee vote, FDA listing or bulks-list effective date, by status.
-
status_source_url - FDA document for the current status.
-
status_as_of - Date we last verified the status.
-
human_trial_count - Registered human trials we reviewed on ClinicalTrials.gov.
-
trial_ids - ClinicalTrials.gov NCT numbers, separated by semicolons.
-
unii - FDA Unique Ingredient Identifier.
-
last_reviewed - Date of the last medical/editorial review (YYYY-MM-DD).
-
last_updated - When this record last changed (ISO 8601).
“Peptide regulatory status tracker.” Tele Launched (dataset). Updated Oct. 27, 2026. Accessed Nov. 7, 2026. https://telelaunched.com/peptides/